✨
AI Summary & Key Takeaways
AI Insight⚡ TL;DR(Too Long; Didn't Read)
Here we report a child with chronic neutropenia in whom intermittent-low doses of G-CSF were successfully used over a long period.
📌 3 Key Takeaways
🎯
Objective & Hypothesis:Chronic neutropenia in childhood has many definable causes and thus a clear cause cannot be identified in a large group of patients.
📊
Key Findings & Data:Since the committled stem cell is involved in this disorder, growth factors such as granulocyte colony-stimulating factor (G-CSF) may play an important role in the treatment of severely affected children.
💡
Conclusion & Impact:Here we report a child with chronic neutropenia in whom intermittent-low doses of G-CSF were successfully used over a long period.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters
Abstract
Chronic neutropenia in childhood has many definable causes and thus a clear cause cannot be identified in a large group of patients. Since the committled stem cell is involved in this disorder, growth factors such as granulocyte colony-stimulating factor (G-CSF) may play an important role in the treatment of severely affected children. Because of the side effects and cost, the use of G-CSF should be restricted to a minimum dose. Here we report a child with chronic neutropenia in whom intermittent-low doses of G-CSF were successfully used over a long period.
🔖
Cite This Article
YETGİN, S., ÖZBEK, N. (2022). İntermittent - low dose G - CSF treatment in a patient with chronic neutropenia. Turkish Journal of Pediatrics, Cilt: 40 - Sayı: 3, 421–424. https://ajindex.com/articles/613500